
Bone Biologics Corporation
BBLGHealthcare|Biotechnology|US
$0.33
+0.01 (+3.00%)
DCF Value
$4.22
Tangible Book / Share
$1.59
Cash / Share
$1.63
Next Earnings Report
Mar 1, 2027
EPS est. -$0.15
Financing Filings (last 12 months)
3
Shelf registrations / offering prospectuses — latest Jul 24, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (1)
Dec 2026
Est. completion
NADegenerative Disc Disease
Evaluation of NB1 Bone Graft Following Lumbar Interbody Arthrodesis
NCT03810573n=30
Recent Press Releases
Bone Biologics Expands Trial Sites
Sep 8, 2026 · GlobeNewsWire
Bone Biologics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Sep 3, 2026 · GlobeNewsWire
Bone Biologics Achieves 32-Month Validated Shelf Life for rhNELL-1
Aug 12, 2026 · GlobeNewsWire
SEC Filings (52)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 26, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Oct 13, 2026 | 25-NSE | DocumentIndex | |
| Sep 29, 2026 | 8-K | Material event | DocumentIndex |
| Sep 16, 2026 | 8-K | Material event | DocumentIndex |
| Aug 28, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Aug 18, 2026 | PRE 14A | Proxy / shareholder vote | DocumentIndex |
| Aug 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Jul 24, 2026 | EFFECT | DocumentIndex | |
| Jul 24, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Jul 23, 2026 | 8-K | Material event | DocumentIndex |
| Jul 20, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Jul 17, 2026 | S-3 | Shelf registration | DocumentIndex |
| Jul 16, 2026 | 8-K | Material event | DocumentIndex |
| Jul 9, 2026 | 8-K | Material event | DocumentIndex |
| Jul 2, 2026 | ARS | Annual report to holders | DocumentIndex |
| Jul 2, 2026 | DEFA14A | Proxy / shareholder vote | DocumentIndex |
| Jul 2, 2026 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| May 14, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Mar 13, 2026 | 8-K | Material event | DocumentIndex |
| Mar 13, 2026 | 424B5 | Offering prospectus | DocumentIndex |
| Mar 2, 2026 | 10-K | Annual report | DocumentIndex |
| Jan 8, 2026 | 8-K | Material event | DocumentIndex |
| Nov 14, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Nov 7, 2025 | SC 13G/A | Passive 5%+ stake | DocumentIndex |
| Sep 26, 2025 | S-8 | Employee stock plan | DocumentIndex |
| Sep 4, 2025 | 8-K | Material event | DocumentIndex |
| Sep 2, 2025 | EFFECT | DocumentIndex | |
| Aug 29, 2025 | S-3/A | Shelf registration | DocumentIndex |
| Aug 14, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Jul 3, 2025 | SC 13G | Passive 5%+ stake | DocumentIndex |
| Jun 30, 2025 | 8-K | Material event | DocumentIndex |
| Jun 30, 2025 | 424B4 | Offering prospectus | DocumentIndex |
| Jun 27, 2025 | EFFECT | DocumentIndex | |
| Jun 26, 2025 | 8-K | Material event | DocumentIndex |
| Jun 24, 2025 | S-3 | Shelf registration | DocumentIndex |
| Jun 24, 2025 | S-1 | IPO / offering registration | DocumentIndex |
| Jun 6, 2025 | 8-K | Material event | DocumentIndex |
| May 30, 2025 | 8-K | Material event | DocumentIndex |
| May 12, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Apr 23, 2025 | ARS | Annual report to holders | DocumentIndex |